Buspirone Hydrochloride Tablet
Product Images NDC 63629-2414

11 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 63629-2414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg ( Two Thirds Of A Tablet) (15mg 10mg)

10 mg ( Two Thirds Of A Tablet) (15mg 10mg)
Buspirone Hydrochloride 30 mg oral tablet imprinted with '9' on one side and '0' on the other side. The tablet is white and scored, shaped like a rectangle with rounded edges, dividing the imprint into two sections.*
FDA Label Image

15 mg (the Entire Tablet) (15mg 15mg)

15 mg (the Entire Tablet) (15mg 15mg)
Buspirone Hydrochloride 30 mg oral tablet imprinted with '093' on one side, shown in a three-digit rectangular imprint divided into three sections. No additional packaging or labeling information is visible in the image.*
FDA Label Image

5 mg (one Third Of A Tablet) (15mg 5mg)

FDA Label Image

7.5 Xxx (15mg 7 5)

7.5 Xxx (15mg 7 5)
Buspirone Hydrochloride 30 mg oral tablet partially visible in white and black capsule-shaped form. The label shows part of the imprint '0' on the capsule. The product is labeled by Bryant Ranch Prepack with NDC 63629-2414.*
FDA Label Image

10 mg (one Third Of A Tablet) (30mg 10mg)

10 mg (one Third Of A Tablet) (30mg 10mg)
Buspirone Hydrochloride 30 mg oral tablet with an imprint '10' visible on the tablet surface. The image shows a close-up of the tablet's shape and imprint used for identification. Manufactured by Bryant Ranch Prepack.*
FDA Label Image

15 mg Entire Tablet (30mg 15mg)

15 mg Entire Tablet (30mg 15mg)
Buspirone Hydrochloride 30 mg oral tablet with a score line and the imprint '10' visible on one side. The image shows the tablet's shape and markings clearly. Labeler is Bryant Ranch Prepack, NDC 63629-2414.*
FDA Label Image

20 mg (two Thirds Of A Tablet) (30mg 20mg)

20 mg (two Thirds Of A Tablet) (30mg 20mg)
Buspirone Hydrochloride 30 mg oral tablet showing a white, capsule-shaped tablet imprinted with "10" on each half.*
FDA Label Image

30 mg (the Entire Tablet) (30mg 30mg)

30 mg (the Entire Tablet) (30mg 30mg)
Buspirone Hydrochloride 30 mg oral tablet shown as a white capsule-shaped tablet scored into three sections, each engraved with the number '10'. No manufacturer or additional labeling details are visible on the tablet.*
FDA Label Image

Break In Half (Break)

Break In Half (Break)
An instructional illustration showing two hands holding a tablet from both sides between thumb and forefinger, demonstrating how to split the tablet by applying pressure with the fingers.*
FDA Label Image

Label (Lbl636292414)

Label (Lbl636292414)
Buspirone Hydrochloride Tablets, USP 30 mg oral tablets are shown on this label by Bryant Ranch Prepack. The label indicates a quantity of 500 tablets and displays the NDC 63629-2414-1. It includes storage instructions, manufacturer and relabeler information, barcode, and a child-resistant container warning. The label is marked Rx only.*
FDA Label Image

Structural Formula (Structural Formula)

Structural Formula (Structural Formula)
Chemical structure of buspirone hydrochloride, depicted as a line-angle molecular formula showing the arrangement of atoms and bonds including cycloalkane, piperazine, and pyrimidine rings, along with an HCl component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.